Ratings by Lake Street (Daniel Brims)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/6/2026 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2026 | Rezolute | RZLT | New Coverage | Buy (N/A) |
4.09 (3.58) |
-12.47% | Details | |
| 9/17/2026 | Kyntra Bio | KYNB | New Coverage | Buy (N/A) |
7.61 (4.85) |
-36.27% | Details | |
| 9/17/2026 | Spruce Biosciences, Inc. | SPRB | New Coverage | Buy (N/A) |
54.16 (39.65) |
-26.79% | Details | |
| 5/28/2026 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
31.66 (25.17) |
-20.5% | Details | |
| 5/28/2026 | Aligos Therapeutics Inc. | ALGS | New Coverage | Buy (N/A) |
5.60 (4.86) |
-13.21% | Details | |
| 4/14/2026 | Kura Oncology | KURA | New Coverage | Buy (N/A) |
8.72 (9.08) |
4.13% | Details | |
| 4/14/2026 | Rani Therapeutics | RANI | New Coverage | Buy (N/A) |
0.78 (0.64) |
-17.95% | Details |
